Tela Bio Inc Expected To Post A Loss Of 52 Cents A Share: Earnings Preview

TELA Bio

09/11/2021 03:08

* TELA Bio Inc  TELA.OQ   TELA.O  is expected to show a rise in
quarterly revenue when it reports  results on November 10. 
* The Malvern, Pennsylvania-based company is expected to report 
a 42.0% increase in revenue to $7.547 million from $5.31 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for TELA Bio Inc is for a
loss of 52 cents per share. For the same quarter last year, the
company reported a loss of 53 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for TELA Bio Inc is
$20​, about 36.4% above​ its last closing price of $12.72. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.53       -0.52      -0.57     Missed  -9.6
 Mar. 31 2021  -0.49       -0.48      -0.56     Missed  -16.1
 Dec. 31 2020  -0.42       -0.49      -0.54     Missed  -10.7​
 Sep. 30 2020  -0.49       -0.49      -0.53     Missed  -9.2
 ​​Jun.        -0.59       -0.59      -0.53     Beat    9.8
 30 2020                                                
 Mar. 31 2020  -0.56       -0.56      -0.63     Missed  -12​
 Dec. 31 2019  -0.58       -0.59      -1.22     Missed  -105
 Sep. 30 2019  -0.56       -0.56      -0.02     Beat    96.4
 This summary was machine generated November 9 at 03:07 GMT.  All
figures in US dollars unless otherwise stated